Implants - Like Probuphine to Treat #Opioid Addiction - Could Replace Pills | Pharmaguy's Insights Into Drug Industry News | Scoop.it

It’s hard to imagine the $450 billion pharmaceutical industry—which makes almost half of its sales on pills, according to QuintlesIMS—abandoning the simple medical tablet altogether, but increasingly it has competition.


Especially formidable is the new class of pharmaceutical implants, matchstick-size devices that deliver drugs to patients over a period of weeks or months, are coming into their own. Titan Pharmaceuticals and Braeburn Pharmaceuticals, for example, have an FDA-approved implantable that, once inserted in the patient’s upper arm, treats opioid addiction by providing continuous doses of buprenorphine.